Next Generation Multi-Omics & Biomarker Profiling
directly from routine tissue images
What we do
Panakeia provides comprehensive ‘omics' molecular analysis of patient tissues significantly faster and cheaper than other methods.
We are creating AI-technology to provide biomarker information directly from H&E-stained tissue images.
Panakeia offers reliable results in minutes rather than multiple physical tests executed over several days or weeks.
Our offerings enhance both clinical diagnostics and drug development.
Hospitals & Labs
Panakeia accelerates the patient pathway by reducing the need for lab-based testing in pathology workflows. Our first
device focuses on breast cancer.
Benefit from our customizable platform and expertise in diagnostic-grade AI to enable your own next generation multiomics profiling.
Join our mission
Panakeia are a team of leading clinicians, scientists and engineers are on a mission to bring the next generation of multi-omics for timely diagnosis and treatment. We are looking for creators and innovators to solve one of the biggest challenges of our times: timely access to quality healthcare.